McBride (MCB) Given New GBX 235 Price Target at Liberum Capital
McBride (LON:MCB) had its price objective decreased by Liberum Capital from GBX 260 ($3.53) to GBX 235 ($3.19) in a research report sent to investors on Monday. Liberum Capital currently has a buy rating on the stock.
MCB has been the subject of several other reports. Numis Securities raised their target price on shares of McBride from GBX 235 ($3.19) to GBX 260 ($3.53) and gave the company a buy rating in a research note on Wednesday, October 4th. Berenberg Bank raised their price objective on shares of McBride from GBX 220 ($2.98) to GBX 240 ($3.25) and gave the stock a buy rating in a research report on Friday, September 29th. Finally, Peel Hunt downgraded shares of McBride to a hold rating and set a GBX 215 ($2.92) price objective for the company. in a research report on Wednesday, October 11th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of GBX 230.83 ($3.13).
Shares of McBride (MCB) opened at GBX 180.37 ($2.45) on Monday. McBride has a one year low of GBX 158.31 ($2.15) and a one year high of GBX 235 ($3.19). The stock has a market cap of $324.00 and a PE ratio of 3,607.44.
McBride plc is a provider of private label household and personal care products. The Company is engaged in developing, producing and supplying its products to retailers across Europe. Its segments include Household, Personal Care & Aerosols (PCA) and Corporate. The Household segment consists of UK; North, including France, Belgium, Holland and Scandinavia; South, including Italy and Spain, and East, including Germany, Poland, Luxembourg and other Eastern Europe.
Receive News & Ratings for McBride Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McBride and related companies with MarketBeat.com's FREE daily email newsletter.